GLP1R and cerebrovascular disorder: Coronary artery disease (aOR, 0.95; 95% CI, 0.92-0.98) and cerebrovascular disease (aOR, 0.96; 95% CI, 0.93-0.98) were both independently associated with lower GLP-1 RA use.